This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
The authors would like to thank D. Ling and M. Behrens for their contributions to this article. The views expressed here are the authors' and do not necessarily represent the views of the partners of Shearman & Sterling or the firm as a whole.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lilienfeld, D., Polovoy, B. & Kessel, M. Ignore the Delaware director-compensation cases at your peril. Nat Biotechnol 34, 373–374 (2016). https://doi.org/10.1038/nbt.3529
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3529